LitCovid-sample-Enju  

PMC:7253482 / 2082-2433 JSONTXT 14 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T319 7-22 NNS denotes countermeasures
T320 23-25 TO denotes to
T321 26-32 VB denotes combat
T322 33-38 DT denotes these
T323 39-48 NNS denotes pathogens
T324 50-57 VBG denotes Ongoing
T325 58-65 NN denotes vaccine
T326 66-77 NN denotes development
T327 78-85 NNS denotes efforts
T328 86-91 NN denotes focus
T329 92-94 IN denotes on
T330 95-98 DT denotes the
T331 99-104 NN denotes spike
T332 105-106 -LRB- denotes (
T333 106-107 NN denotes S
T334 107-108 -RRB- denotes )
T335 109-117 NNS denotes proteins
T336 118-122 WDT denotes that
T337 123-131 VBP denotes protrude
T338 132-136 IN denotes from
T339 137-140 DT denotes the
T340 141-146 JJ denotes viral
T341 147-155 NN denotes envelope
T342 156-159 CC denotes and
T343 160-170 VB denotes constitute
T344 171-174 DT denotes the
T345 175-179 JJ denotes main
T346 180-186 NN denotes target
T347 187-189 IN denotes of
T348 190-202 VBG denotes neutralizing
T349 203-216 NN denotes antibodies7,8
T350 218-223 DT denotes These
T351 224-232 JJ denotes trimeric
T352 233-234 NN denotes S
T353 235-243 NNS denotes proteins
T354 244-251 VBP denotes mediate
T355 252-261 JJ denotes host-cell
T356 262-267 NN denotes entry
T357 268-272 IN denotes with
T358 273-276 DT denotes the
T359 277-279 NN denotes S1
T360 280-283 CC denotes and
T361 284-286 NN denotes S2
T362 287-295 NNS denotes subunits
T363 296-307 JJ denotes responsible
T364 308-311 IN denotes for
T365 312-319 VBG denotes binding
T366 320-322 TO denotes to
T367 323-326 DT denotes the
T368 327-336 NN denotes host-cell
T369 337-345 NN denotes receptor
T370 346-349 CC denotes and
R316 T321 T320 arg1Of combat,to
R317 T319 T321 arg1Of countermeasures,combat
R318 T323 T321 arg2Of pathogens,combat
R319 T323 T322 arg1Of pathogens,these
R320 T328 T324 arg1Of focus,Ongoing
R321 T328 T325 arg1Of focus,vaccine
R322 T328 T326 arg1Of focus,development
R323 T328 T327 arg1Of focus,efforts
R324 T328 T329 arg1Of focus,on
R325 T335 T329 arg2Of proteins,on
R326 T335 T330 arg1Of proteins,the
R327 T335 T331 arg1Of proteins,spike
R328 T335 T332 arg1Of proteins,(
R329 T333 T332 arg2Of S,(
R330 T334 T332 arg3Of ),(
R331 T335 T336 arg1Of proteins,that
R332 T335 T337 arg1Of proteins,protrude
R333 T337 T338 arg1Of protrude,from
R334 T341 T338 arg2Of envelope,from
R335 T341 T339 arg1Of envelope,the
R336 T341 T340 arg1Of envelope,viral
R337 T337 T342 arg1Of protrude,and
R338 T343 T342 arg2Of constitute,and
R339 T335 T343 arg1Of proteins,constitute
R340 T346 T343 arg2Of target,constitute
R341 T346 T344 arg1Of target,the
R342 T346 T345 arg1Of target,main
R343 T346 T347 arg1Of target,of
R344 T348 T347 arg2Of neutralizing,of
R345 T349 T348 arg2Of "antibodies7,8",neutralizing
R346 T353 T350 arg1Of proteins,These
R347 T353 T351 arg1Of proteins,trimeric
R348 T353 T352 arg1Of proteins,S
R349 T353 T354 arg1Of proteins,mediate
R350 T356 T354 arg2Of entry,mediate
R351 T356 T355 arg1Of entry,host-cell
R352 T354 T357 arg1Of mediate,with
R353 T362 T357 arg2Of subunits,with
R354 T362 T358 arg1Of subunits,the
R355 T362 T359 arg1Of subunits,S1
R356 T359 T360 arg1Of S1,and
R357 T361 T360 arg2Of S2,and
R358 T362 T361 arg1Of subunits,S2
R359 T362 T363 arg1Of subunits,responsible
R360 T363 T364 arg1Of responsible,for
R361 T370 T364 arg2Of and,for
R362 T365 T366 arg1Of binding,to
R363 T369 T366 arg2Of receptor,to
R364 T369 T367 arg1Of receptor,the
R365 T369 T368 arg1Of receptor,host-cell
R366 T365 T370 arg1Of binding,and